Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in AYTU — Aytu Biopharma, Inc

CIK 1037389 NEW YORK, NY
Back to AYTU Full portfolio

Position in AYTU

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$225,369
-$30,494 QoQ
Shares Held
104,823
+11.8% QoQ
Ownership
0.977%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 38 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AYTU Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $2,242,873,379 across 49 Drug Manufacturers - Specialty & Generic names. AYTU ranks #41 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 1,708,739 $925,846,052
2 NBIX
Neurocrine Biosciences Inc
 2,335,897 $393,692,080
3 ALKS
Alkermes plc.
 6,460,928 $338,552,627
4 RDY
Dr Reddys Laboratories Ltd
 7,347,028 $106,458,435
5 ZTS
Zoetis Inc.
 1,403,300 $100,841,138
6 SUPN
Supernus Pharmaceuticals, Inc.
 1,478,180 $68,750,151
7 COLL
Collegium Pharmaceutical, Inc
 1,366,549 $49,469,073
8 PCRX
Pacira BioSciences, Inc.
 1,733,801 $43,986,531

All Filings in AYTU

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $225,369 104,823
2026-03-31 $255,863 93,723
2025-12-31 $233,019 89,623
2025-09-30 $178,831 95,123
2025-06-30 $196,010 89,913
2025-03-31 $92,187 76,823
2024-12-31 $128,219 75,423
2024-09-30 $175,599 74,723
2024-06-30 $216,439 74,123
2024-03-31 $216,821 71,323
2023-12-31 $195,741 68,923
2023-09-30 $163,952 60,723
2023-06-30 $91,716 57,323
2023-03-31 $111,155 49,623
2022-12-31 $406,748 2,140,782
2022-09-30 $332,028 1,747,520
2022-06-30 $728,489 1,055,782
2022-03-31 $826,706 765,469
2021-12-31 $897,843 665,069
2021-09-30 $1,902,539 660,604
2021-06-30 $2,391,618 477,369
2021-03-31 $991,959 130,521
2020-06-30 $93,720 66,000
2020-03-31 $458,400 305,600